ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 150 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,474,910 | +3334.9% | 902,095 | +3229.3% | 0.01% | – |
| Q2 2023 | $537,864 | +16.1% | 27,096 | +0.2% | 0.00% | – |
| Q1 2023 | $463,157 | +73.5% | 27,030 | +98.0% | 0.00% | – |
| Q4 2022 | $266,930 | -23.3% | 13,650 | -14.5% | 0.00% | – |
| Q4 2021 | $348,000 | -99.1% | 15,957 | -98.7% | 0.00% | -100.0% |
| Q3 2021 | $36,751,000 | -32.8% | 1,229,498 | -0.5% | 0.02% | -30.4% |
| Q2 2021 | $54,721,000 | -0.6% | 1,235,489 | -0.5% | 0.02% | -8.0% |
| Q1 2021 | $55,077,000 | -21.4% | 1,241,316 | -2.8% | 0.02% | -24.2% |
| Q4 2020 | $70,043,000 | +3815.2% | 1,277,310 | +1532.0% | 0.03% | +3200.0% |
| Q3 2020 | $1,789,000 | +16.3% | 78,267 | +6.4% | 0.00% | 0.0% |
| Q2 2020 | $1,538,000 | +62.2% | 73,569 | +8.2% | 0.00% | 0.0% |
| Q1 2020 | $948,000 | – | 67,990 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 16,037,486 | $280,250,000 | 19.13% |
| TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $52,015,000 | 9.58% |
| Boxer Capital, LLC | 1,466,051 | $25,715,000 | 2.97% |
| Ghost Tree Capital, LLC | 600,000 | $10,524,000 | 2.75% |
| BRIDGER MANAGEMENT, LLC | 1,529,032 | $26,819,000 | 2.12% |
| Cormorant Asset Management, LP | 1,700,000 | $29,818,000 | 2.02% |
| EcoR1 Capital, LLC | 450,000 | $7,893,000 | 0.73% |
| UNIVERSITY OF NOTRE DAME DU LAC | 171,015 | $3,000,000 | 0.67% |
| Virtus ETF Advisers LLC | 17,799 | $312,000 | 0.66% |
| SPHERA FUNDS MANAGEMENT LTD. | 290,001 | $5,087,000 | 0.46% |